RE:RE:RE:It's not NailoserI have to agree, I do not see StageZero disclosing Aristotle sales.
Where I do disagree is potentially seeing an increase in Covid testing revenues for Q4. It would be nice ot see this, but realistically, there were many other cheaper PCR testing options in the last month or two of 2021. So unless travel ramped by 200%+ and StageZero saw an equal increase in the demand of the Covid testing, then I would expect a decrease in the Covid testing revenues.
molotov420 wrote: unfortunately we're not even going to be told what Aristotle revenue was....they will lump it with Covid again and call it "Lab Revenue"...should see an increase in revenue though. The last quarter of Covid testing should be pretty busy due to Omicron and hopefully Sobeys brought something. If they sold any Aristotle, revs should be better than Q3